The study is a 'real-world' study which evaluates the safety and performance of the coronary DES-CRE8 in diabetic patients.
As routine care, each patient will be followed until 12 months after stent implantation.
Treatment | DES-CRE8 |
---|---|
Clinical Study Identifier | NCT03842813 |
Sponsor | Alvimedica Medical Technologies France |
Last Modified on | 21 April 2019 |
Select a piece of text and start making personal notes.
,
You have contacted , on
Your message has been sent to the study team at ,
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerCongrats! You have your own personal workspace now.